All tirzepatide doses were superior to all comparators in terms of reducing body weight
As a result, SGLT2 inhibitors are now recommended as first add-on (or even first-line, alongside metformin) when someone has established cardiovascular disease, heart failure, or chronic kidney disease: even if their HbA1c is at target
doi: 10.3389/fendo.2022.824215 39 StrattonIMHolmanRRBoultonAJ
Nitric oxide isnt a new area of research in cardiovascular science
388,389 Butyrate enhances the integrity of the blood-nerve barrier and reduces inflammatory cytokine production, protecting peripheral nerves from damage
Clinical trials show that higher doses correlate with greater weight loss, and a dose increase often restarts progress within 46 weeks